MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Propantheline

Propantheline bromide 15mg tablets

Use with caution

Stability notes for Propantheline bromide 15mg tablets

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Pro-Banthine 15mg tablets (Kyowa Kirin Ltd).

Suppliers (4) of Propantheline bromide 15mg tablets
Pro-Banthine 15mg tablets (Grunenthal Ltd)
Propantheline bromide 15mg tablets (A A H Pharmaceuticals Ltd)
Propantheline bromide 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Propantheline bromide 15mg tablets (Genesis Pharmaceuticals Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.